Abiopharma

New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2026-01-06 AccNo: 0001214659-26-000192 Size: 18 KB

New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2026-01-06 AccNo: 0001214659-26-000191 Size: 18 KB

New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2026-01-06 AccNo: 0001214659-26-000190 Size: 18 KB

New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2026-01-06 AccNo: 0001214659-26-000189 Size: 17 KB

New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2026-01-06 AccNo: 0001214659-26-000193 Size: 20 KB

New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2026-01-06 AccNo: 0001214659-26-000188 Size: 18 KB

Director Bassler Bonnie L 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000004

Eylward Susan 🟢 acquired 8.3K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000609

Lurker Nancy 🟡 adjusted position in 40.0K shares (2 derivative) of EyePoint, Inc. (EYPT) at $17.48 Transaction Date: Jan 02, 2026 | Filing ID: 000003

Anderman Todd 🟢 acquired 262.6K shares (1 derivative) of OCULAR THERAPEUTIX, INC (OCUL) at $11.82 ($2.3M) Transaction Date: Jan 02, 2026 | Filing ID: 001296

Director Lewis William 🟢 acquired 131.6K shares (1 derivative) of INSMED Inc (INSM) at $177.12 ($19.6M) Transaction Date: Jan 02, 2026 | Filing ID: 000003

Director Pellizzari Christine A 🟢 acquired 4.8K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000608

📋 CHRISTOPHER CAUSEY (Director) plans to sell 1K shares of UNITED THERAPEUTICS CORPORATION (at $510.00 each, total $510K) Filed: Jan 06, 2026 | ID: 000176

📋 JULA INRIG (Officer) plans to sell 445 shares of TRAVERE THERAPEUTICS, INC. (at $37.75 each, total $17K) Filed: Jan 06, 2026 | ID: 000175

Landis John B. 🟢 acquired 40.0K shares (1 derivative) of EyePoint, Inc. (EYPT) at $17.48 Transaction Date: Jan 02, 2026 | Filing ID: 000002